Login/ Register

administrator

Unraveling the enigma of long COVID: novel aspects in pathogenesis, diagnosis, and treatment protocols

“Unraveling the enigma of long COVID: novel aspects in pathogenesis, diagnosis, and treatment protocols” published in Inflammopharmacology is a comprehensive review exploring the complex nature of long COVID. https://link.springer.com/article/10.1007/s10787-024-01483-2  

Unraveling the enigma of long COVID: novel aspects in pathogenesis, diagnosis, and treatment protocols Read More »

Pseudouridine, mRNA Vaccines & Spike Protein Persistence

The mRNA vaccines developed by Pfizer and Moderna for COVID-19 contain engineered mRNA encoding the spike protein of the SARS-CoV-2 virus. This mRNA differs slightly from the viral mRNA, employing a stabilizing modification using pseudouridine. Recent studies have shown that the vaccine mRNA can persist in the body for several weeks, raising questions about potential

Pseudouridine, mRNA Vaccines & Spike Protein Persistence Read More »

SARS-CoV-2, long COVID, prion disease and neurodegeneration

The evidence suggests a strong link between SARS-CoV-2 infection, long COVID, and the development or acceleration of neurodegenerative diseases. The mechanisms underlying this relationship appear to involve the prion-like properties of the SARS-CoV-2 spike protein, shared inflammatory pathways, and the widespread distribution of the ACE2 receptor in the brain. Further research is needed to fully

SARS-CoV-2, long COVID, prion disease and neurodegeneration Read More »

Review: N1-methyl-pseudouridine (m1Ψ): Friend or foe of cancer?

The document titled “Review: N1-methyl-pseudouridine (m1Ψ): Friend or foe of cancer?” authored by Alberto Rubio-Casillas and colleagues, provides a comprehensive review of the role of N1-methyl-pseudouridine (m1Ψ) in the context of cancer, particularly focusing on its implications when used in mRNA vaccines, such as those developed for COVID-19. The review highlights the rapid development and

Review: N1-methyl-pseudouridine (m1Ψ): Friend or foe of cancer? Read More »

Effects of COVID-19 and vaccination on the human immune system: cases of lymphopenia and autoimmunity

The article from Future Virology, authored by J Gerlach and AM Baig, discusses the effects of COVID-19 and vaccination on the human immune system, particularly focusing on cases of lymphopenia and autoimmunity. The study explores the possibility that some individuals may be more prone to developing an immune response to self-antigens after COVID-19 infection and

Effects of COVID-19 and vaccination on the human immune system: cases of lymphopenia and autoimmunity Read More »

SARS-COV-2 Spike Protein causes prionlike diseases

Based on the additional search results provided, the key information about the “spike532” sequence and its relation to prion protein biogenesis is: The spike532 sequence refers to a specific region within the SARS-CoV-2 spike protein that has been identified as having prion-like properties[2]. Specifically, the search results indicate that the spike532 sequence contains signal sequences

SARS-COV-2 Spike Protein causes prionlike diseases Read More »

Scroll to Top

Team Member 1

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.